A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

June 12, 2024

Study Completion Date

June 12, 2024

Conditions
Advanced Non-small Cell Lung CancerEGFR MutationHER2 MutationHealthy Volunteers
Interventions
DRUG

BAY2927088

Oral

DRUG

Itraconazole

Capsule, 100 mg, oral.

DRUG

Carbamazepine

Tablet, 100 mg, 200mg and 300mg, oral.

Trial Locations (1)

21225

Parexel Baltimore - Early Phase Clinical Unit, Baltimore

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY

NCT06348888 - A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants | Biotech Hunter | Biotech Hunter